D. Adson

发表

Effect of quetiapine vs. placebo on response to two virtual public speaking exposures in individuals with social phobia.

Matt G Kushner, Christopher B. Donahue, M. Kushner, 2009, Journal of anxiety disorders.

Physiological response to a speech stressor presented in a virtual reality environment.

Michael Kotlyar, Matt G Kushner, Christopher B. Donahue, 2008, Psychophysiology.

Effect of stress and bupropion on craving, withdrawal symptoms, and mood in smokers.

M. al’Absi, L. Brauer, D. Hatsukami, 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Morbidity and Mortality

D. Adson, M. Kotlyar, Abby E Von Ruden, 2008, Journal of cardiovascular pharmacology and therapeutics.

A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination

J. Pardo, G. Schwindt, F. Abuzzahab, 2019, bioRxiv.

A preliminary study of resting brain metabolism in treatment-resistant depression before and after treatment with olanzapine-fluoxetine combination

Barry R. Rittberg, J. Pardo, G. Schwindt, 2019, bioRxiv.

Preliminary experience with adjunctive quetiapine in patients receiving selective serotonin reuptake inhibitors

S. Schulz, M. Kushner, D. Adson, 2004, Depression and anxiety.

Inhibition of CYP2D6 Activity by Bupropion

L. Brauer, D. Hatsukami, D. Adson, 2005, Journal of clinical psychopharmacology.

The selectivity of inclusion and exclusion criteria in bulimia nervosa treatment studies.

D. D. Maki, D. Adson, S. Crow, 1997, The International journal of eating disorders.

The superior mesenteric artery syndrome and acute gastric dilatation in eating disorders: a report of two cases and a review of the literature.

D. Adson, James E Mitchell, J. Mitchell, 1997, The International journal of eating disorders.

Premature Ejaculation Associated with Citalopram Withdrawal

D. Adson, M. Kotlyar, 2003, The Annals of pharmacotherapy.

Weight loss during chronic, cervical vagus nerve stimulation in depressed patients with obesity: an observation

Barry R. Rittberg, J. Pardo, M. Kuskowski, 2007, International Journal of Obesity.

Aripiprazole Augmentation in Major Depressive Disorder: A Double-Blind, Placebo-Controlled Study in Patients with Inadequate Response to Antidepressants

M. Fava, M. Trivedi, M. Thase, 2009, CNS Spectrums.

Potential drug-drug interactions on a tertiary-care hospital consultation-liaison psychiatry service.

D. Adson, S. Crow, W. Meller, 1998, Psychosomatics.

Update on drug-induced depression in the elderly.

D. Adson, M. Dysken, M. Kotlyar, 2005, The American journal of geriatric pharmacotherapy.

Effect of Paroxetine on Physiological Response to Stress and Smoking

M. al’Absi, D. Hatsukami, P. Thuras, 2013, Psychosomatic medicine.

A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.

Suck-Won Kim, D. Adson, Y. Shin, 2002, The Journal of clinical psychiatry.

D-Cycloserine Augmented Exposure Therapy for Obsessive-Compulsive Disorder

Christopher B. Donahue, E. Foa, M. Kushner, 2007, Biological Psychiatry.

Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: a placebo-controlled, randomized study.

D. Adson, W. Earley, H. Eriksson, 2011, Journal of affective disorders.

Effect of bupropion on physiological measures of stress in smokers during nicotine withdrawal

M. al’Absi, L. Brauer, D. Hatsukami, 2006, Pharmacology Biochemistry and Behavior.

Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors.

M. Kushner, D. Adson, Tamara Fahnhorst, 2005, Journal of affective disorders.

Preliminary communication Treatment of residual anxiety symptoms with adjunctive aripiprazole in depressed patients taking selective serotonin reuptake inhibitors

M. Kushner, D. Adson, Tamara Fahnhorst, 2005 .

Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling

Suck-Won Kim, D. Adson, Y. Shin, 2001, Biological Psychiatry.

Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism

José V. Pardo, Joel T. Lee, Sohail A. Sheikh, 2008, NeuroImage.

Urge to Gamble in a Simulated Gambling Environment

Christopher B. Donahue, M. Kushner, K. Abrams, 2008, Journal of Gambling Studies.

A preliminary report on possible naltrexone and nonsteroidal analgesic interactions.

Suck-Won Kim, D. Adson, J. Grant, 2001, Journal of clinical psychopharmacology.

- Cycloserine Augmented Exposure Therapy for bsessive-Compulsive Disorder

Christopher B. Donahue, E. Foa, J. Peterson, 2007 .

An Unusual Presentation of Sertraline and Trazodone Overdose

D. Adson, M. Kotlyar, Sherrie L Erickson-Birkedahl, 2001, The Annals of pharmacotherapy.

Considering long-term outcome and tolerability in the treatment of bipolar disorder

D. Adson, 2004 .

Effect of Selective Serotonin Reuptake Inhibitors on Cardiovascular Morbidity and Mortality

D. Adson, M. Kotlyar, Abby E Von Ruden, 2008, Journal of cardiovascular pharmacology and therapeutics.

Effect of Paroxetine on Physiological Response to Stress and Smoking

M. al’Absi, D. Hatsukami, P. Thuras, 2013, Psychosomatic medicine.